Skip to main navigation Skip to search Skip to main content

Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma

  • H. Einsele
  • , S. Knop
  • , M. Vogel
  • , J. Müller
  • , M. Kropff
  • , B. Metzner
  • , C. Langer
  • , H. Sayer
  • , W. Jung
  • , H. A. Dürk
  • , H. Salwender
  • , H. Wandt
  • , F. Bassermann
  • , M. Gramatzki
  • , W. Rösler
  • , H. H. Wolf
  • , W. Brugger
  • , M. Engelhardt
  • , T. Fischer
  • , P. Liebisch
  • C. Straka
  • University of Würzburg
  • Janssen-Cilag
  • acromion GmbH
  • Universitätsklinikum Münster
  • Klinikum Oldenburg
  • University Medical Center Ulm and Center of Excellence 'Metabolic Disorders'
  • University Heart Center
  • University Medical Center
  • St. Marien-Hospital Hamm
  • Asklepios Klinik Hamburg
  • Medizinische Klinik
  • University Hospital Schleswig-Holstein
  • Universitätsklinikum Erlangen
  • University Hospital
  • Schwarzwald-Baar Klinikum Villingen-Schwenningen GmbH
  • University of Freiburg
  • Otto-von-Guericke University
  • Schön Klinik Starnberger See

Research output: Contribution to journalLetterpeer-review

20 Scopus citations
Original languageEnglish
Pages (from-to)1463-1466
Number of pages4
JournalLeukemia
Volume31
Issue number6
DOIs
StatePublished - 1 Jun 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this